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Sickle Cell Disease in Georgia Findings From rusH
Facts For Providers
What is RuSH?
 • Registry and Surveillance System for Hemoglobinopathies 
(RuSH) was a pilot project of the Centers for Disease 
Control and Prevention (CDC), with the National Institutes 
of Health’s National Heart, Lung, and Blood Institute.
 • The overall purpose of RuSH was to collect state-specific, 
population-based data on people with sickle cell disease 
(SCD) and thalassemia in order to provide accurate 
updated information to the public.
 • Seven states were funded to participate in data collection: 
California, Florida, Georgia, Michigan, New York, North 
Carolina, and Pennsylvania.
What is Sickle Cell Disease?
 • SCD is a group of inherited conditions that affect 
hemoglobin, a protein that allows red blood cells  
to carry oxygen to all parts of the body. 
 • People with ancestry from parts of Africa, Asia and  
the Mediterranean are among the most likely to be born 
with these conditions.
 • Healthy red blood cells are round, and they move through 
small blood vessels to carry oxygen to all  
parts of the body. In SCD, the red blood cells  
become hard and sticky and look like a C-shaped  
farm tool called a “sickle.” 
 • These cells can get stuck in the blood vessels and  
block the normal flow of oxygen throughout the  
body. This leads to a variety of health problems. 
 • The most common types of SCD are:
 ο Hemoglobin SS Disease (HbSS): People who have this 
form of SCD inherit two sickle cell hemoglobin genes 
(“S”), one from each parent. This is commonly called 
sickle cell anemia and is usually the most severe form of 
the disease.
 ο Hemoglobin SC Disease (HbSC): People who have this 
form of SCD inherit a sickle cell hemoglobin gene (“S”) 
from one parent and from the other parent a gene for 
abnormal hemoglobin called “C”. This is usually a milder 
form of SCD.
 ο Hemoglobin S beta thalassemia (HbS beta thalassemia): 
People who have this form of SCD inherit one sickle cell 
hemoglobin gene (“S”) from one parent and one gene 
for beta thalassemia, another type of anemia, from the 
other parent. There are two types of beta thalassemia: 
“0” and “+”. Those with HbS beta0-thalassemia usually 
have a more severe form of SCD. People with HbS 
beta+-thalassemia tend to have a milder form of SCD.
The Sickle Cell Population in Georgia
SCD occurs in individuals of all geographic and ethnic 
backgrounds. We estimate that 97% or more of Georgia 
newborns with SCD are Black or African-American, and roughly 
2% overall are of Hispanic-American ethnicity. This means that 
about 1 out of every 295 Black or African-American babies born 
in Georgia from 2004 through 2008 had some form of SCD. 
Types of SCD in babies born in Georgia, 2004-2008
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Through our surveillance efforts, we found 7,299 individuals 
with confirmed or probable SCD in Georgia. Of these, 4,288 had 
a diagnosis confirmed by a clinical center or through newborn 
screening. The rest were identified because they had a sickle 
cell diagnosis in one of the administrative datasets (hospital or 
public insurance claims data) as well as health care utilization 
consistent with SCD.1  These 7,299 individuals live in virtually 
every county throughout the state of Georgia.
1Based on CDC RuSH definition
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We identified individuals living with SCD from newborns to those 
over 70 years of age; the figure below shows the age distribution 
of identified cases. Because our surveillance methods relied heavily 
on utilization data from newborn screening follow-up facilities and 
public health insurance programs, we were more likely to identify 
children living with the disease than their adult counterparts. The 
decreased prevalence by age of people living with SCD illustrated 
by the figure is in part due to our surveillance methods and not 
only a reflection of early mortality from the disease.
Age distribution of individuals with SCD in Georgia 
identified by RuSH
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Health and Health Care
Again, because our surveillance methods relied on health care 
utilization data and insurance claims, individuals with SCD who 
did not seek care—some who were uninsured and some whose 
disease was well managed—were less likely captured in our results. 
The following health and health care utilization results, therefore, 
likely represent those with greater health needs.  
Of the 7,299 individuals with SCD identified, we have access to 
utilization data for 94 percent (6,881) of them.  Twenty-six percent 
(1,798/6,881) had no hospitalizations, and 16 percent (1,131/6,881) 
had no ER visits during the five-year period from 2004 to 2008.  The 
figure below illustrates the five-year average number of hospital 
admissions and ER visits by age group.  This health care utilization 
Average number of hospital encounters per 
individual with SCD, by age group, 2004-2008
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shows a pronounced increase after childhood. While 
children age 0-19 averaged roughly four ER visits and 
three hospitalizations over five years, those age 20 
through 49 had more than fifteen ER visits in addition 
to a greater frequency of hospital admissions. Although 
not assessed by our surveillance, this may be in part 
related to the natural history of the condition; factors 
directly related to the transition from parental care to 
independence, from pediatric to adult medical care, 
and to changes in health insurance coverage. Transition 
to independent self-care from parent directed 
management may require some learning.  In addition, 
a break in the primary care medical home may cause 
discontinuity in crucial primary prevention and clinical 
support for patients with SCD.
What you can do
 • Learn more about SCD:
 ο Sickle Cell Information Center website: 
scinfo.org
 ο Comprehensive Sickle Cell Center at Georgia 
Regents University: 706-721-2171
 ο Georgia Comprehensive Sickle Cell Center at 
Grady Health System: 404-616-3572
 ο Aflac Cancer and Blood Disorders Center of 
Children’s Healthcare of Atlanta: 404-785-1200
 • Report babies and children with SCD to the 
Department of Public Health (sickle cell is a 
notifiable disease for children through age 18 in 
Georgia): health.state.ga.us/epi/disease/report;  
404-657-2588
 • Refer SCD patients and families for information  
and support services: Sickle Cell Foundation of 
Georgia, Inc.: www.sicklecellga.org; 404-755-1641; 
800-326-5287 (toll-free)
 • Educate patients on the role of newborn 
screening: Georgia Department of Public Health 
Newborn Screening Program health.state.ga.us/
programs/nsmscd; 404-657-4143
 • Submit samples for confirmatory testing 
to Georgia’s reference laboratory  for 
hemoglobinopathies, the Titus HJ Huisman 
Hemoglobinopathy Laboratory at Georgia 
Regents University: georgiahealth.edu/centers/
sicklecell; 706-721-9640
 • Learn more  about the RuSH Project: Angela 
Snyder, angiesnyder@gsu.edu
For more information on SCD, please visit www.cdc.gov/ncbddd/sicklecell 
